| Category | Subscription | Shares Offered | % of Total | Amount (₹Cr) |
|---|---|---|---|---|
|
QIB
|
Over 1.00x
|
— | — | — |
|
NII / HNI
|
Over 1.00x
|
— | — | — |
|
Retail
|
Over 1.00x
|
— | — | — |
| Total | 1.00x | 43,196,968 |
100% | ₹6,479.55 |
| Category | Shares Offered | Amount (₹Cr) | Size (%) |
|---|---|---|---|
| Total | 43,196,968 | ₹6,479.55 |
100.00%
|
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min — 2 Lots) | 2 | 20 | ₹30,000 |
| Retail (Max — 13 Lots) | 13 | 130 | ₹195,000 |
| S-HNI (Min — 14 Lots) | 14 | 140 | ₹210,000 |
| B-HNI (Min — 68 Lots) | 68 | 680 | ₹1,020,000 |
| Particulars | 30-June-20 | 31-Mar-20 | 31-Mar-19 |
|---|---|---|---|
| Revenue from Operations | 916.29 | 2772.41 | 2129.77 |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | 313.59 | 772.86 | 451.86 |
| Net Worth | N/A | N/A | N/A |
| Total Assets | 4691.27 | 4086.04 | 3523.55 |
| Reserves & Surplus | N/A | N/A | N/A |
| Borrowings | N/A | N/A | N/A |
| EBITDA Margin (%) | N/A | — | — |
| PAT Margin (%) | N/A | — | — |
Gland Pharma Ltd. IPO is subscribed 1.00 times by Nov 11, 2020. Retail: 1.00x. QIB: 1.00x. NII: 1.00x.
| Investor Category | Subscription |
|---|---|
| Qualified Institutional (QIB) | 1.00x |
| Non Institutional (NII/HNI) | 1.00x |
| Retail Individual | 1.00x |
| Total Subscription | 1.00x |
The Gland Pharma Ltd. IPO retail category is subscribed 1.00 times as of 11 Nov 2020. The retail portion is oversubscribed.
Subscribe via your broker app using ASBA or UPI. Opens 09 Nov 2020 and closes 11 Nov 2020. Min investment: ₹15,000 (1 lot = 10 shares). UPI mandate: 2020-11-11.
The Gland Pharma Ltd. IPO subscribed 1.00x overall. QIB: 1.00x, NII: 1.00x, Retail: 1.00x. Applications: from NSE/BSE.
Check allotment on the registrar website (MUFG Intime India Pvt.Ltd.) at https://linkintime.co.in/Initial_Offer/public-issues.html. Enter your PAN, application number or DP/Client ID. Allotment date: 17 Nov 2020. Refunds: on 18 Nov 2020.
The Gland Pharma Ltd. IPO listing date is 20 Nov 2020, Friday. Listed on: NSE & BSE. Issue price: ₹1,500. Estimated listing: ₹1,500. GMP: NIL.
The Gland Pharma Ltd. IPO closes on 11 Nov 2020, Wednesday. UPI mandate: 2020-11-11. Allotment: 17 Nov 2020. Listing: 20 Nov 2020.